Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab
Background: Natalizumab provides rapid and high-efficacy control of multiple sclerosis disease activity with long-term stabilization. However, the benefits of the drug are countered by a risk of developing progressive multifocal leukoencephalopathy in patients infected with the John Cunningham Virus...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Article (Journal) |
| Lingua: | inglese |
| Pubblicazione: |
12 July 2016
|
| In: |
BMC neurology
Year: 2016, Volume: 16 |
| ISSN: | 1471-2377 |
| DOI: | 10.1186/s12883-016-0625-0 |
| Accesso online: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12883-016-0625-0
|
| Note sull'autore: | Tjalf Ziemssen, Achim Gass, Jens Wuerfel, Antonios Bayas, Björn Tackenberg, Volker Limmroth, Ralf Linker, Mathias Mäurer, Judith Haas, Martin Stangel, Matthias Meergans, Olof Harlin and Hans-Peter Hartung |
Search Result 1
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple s...
BioMed Central; Springer 2016
Article (Journal)
Book/Monograph
Online Resource